Commonwealth Equity Services’s Verona Pharma VRNA Stock Holding History

Commonwealth Equity Services’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,336	Closed	-$1.42M	–	4456
2025 Q3	$1.42M	Sell	13,336 -1,214	-8%	-$127K	﹤0.01%	2298
2025 Q2	$1.38M	Sell	14,550 -1,000	-6%	-$74K	﹤0.01%	2308
2025 Q1	$987K	Buy	15,550 +740	+5%	+$44.3K	﹤0.01%	2467
2024 Q4	$688K	Sell	14,810 -681	-4%	-$25.6K	﹤0.01%	2716
2024 Q3	$446K	Buy	+15,491	New	+$381K	﹤0.01%	2986
2023 Q3	–	Sell	-11,960	Closed	-$253K	–	3940
2023 Q2	$253K	Sell	11,960 -11,729	-50%	-$250K	﹤0.01%	3190
2023 Q1	$475	Buy	23,689 +11,180	+89%	+$241K	﹤0.01%	2605
2022 Q4	$326K	Buy	+12,509	New	+$167K	﹤0.01%	2807

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Commonwealth Equity Services's VRNA Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 13,336 shares — an estimated $1.42M sold.

Commonwealth Equity Services first reported a position in VRNA in Q4 2022 and held it in 8 quarters. The position peaked at $1.42M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Commonwealth Equity Services reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Commonwealth Equity Services sold 13,336 Verona Pharma shares in Q4 2025, an estimated $1.42M.
Commonwealth Equity Services first reported a position in Verona Pharma in Q4 2022 and held it in 8 quarters.
Commonwealth Equity Services's Verona Pharma position peaked at $1.42M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.